| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SIGISelective Insurance Group, Inc. | 5.01B | 82.97 | 25.69 | 14.87% | 7.78% | 11.65% | 21.33% | 0.16 |
| LLoews Corporation | 21.32B | 103.16 | 16.09 | 9.96% | 8.07% | 7.55% | 11.22% | 0.50 |
| WRBW. R. Berkley Corporation | 26.11B | 68.71 | 15.76 | 12.32% | 13.01% | 19.44% | 13.68% | 0.34 |
| THGThe Hanover Insurance Group, Inc. | 6.05B | 170.15 | 14.54 | 4.25% | 9.75% | 18.44% | 13.15% | 0.28 |
| CBChubb Limited | 118.5B | 301.11 | 13.26 | 12% | 16.48% | 12.43% | 13.66% | 0.22 |
| CNACNA Financial Corporation | 12.56B | 46.42 | 13.19 | 6.66% | 6.84% | 8.81% | 19.71% | 0.28 |
| TRVThe Travelers Companies, Inc. | 60.53B | 271.34 | 12.64 | 12.22% | 12.13% | 18.58% | 14.99% | 0.29 |
| AFGAmerican Financial Group, Inc. | 11B | 131.90 | 12.48 | 7.12% | 9.7% | 16.87% | 10.47% | 0.33 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.05B | 3.97B | 4.27B | 4.47B | 4.89B | 4.82B | 5.16B | 5.43B | 5.96B | 6.22B |
| Revenue Growth % | -0% | -0.21% | 0.08% | 0.05% | 0.1% | -0.01% | 0.07% | 0.05% | 0.1% | 0.04% |
| Medical Costs & Claims | 3.92B | 3.35B | 3.42B | 3.62B | 3.79B | 3.8B | 4.12B | 4.72B | 5.31B | 4.98B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 1.13B | 616M | 847.6M | 849.7M | 1.1B | 1.02B | 1.04B | 716.3M | 652.9M | 1.24B |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 0.03% | -0.46% | 0.38% | 0% | 0.29% | -0.07% | 0.02% | -0.31% | -0.09% | 0.9% |
| Operating Expenses | 691.6M | 550M | 554.7M | 567.2M | 576.4M | 577.6M | 521.4M | 572.3M | 611.8M | 699.9M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 30.2M | 30.7M | 30.1M | 24.6M | 21.6M | 18.2M | 16.9M | 12.9M | 6.3M | 1.5M |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 439.4M | 66M | 292.9M | 282.5M | 522.1M | 444.8M | 521.3M | 144M | 41.1M | 537.8M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 0.16% | -0.85% | 3.44% | -0.04% | 0.85% | -0.15% | 0.17% | -0.72% | -0.71% | 12.09% |
| EBITDA | 469.6M | 96.7M | 323M | 307.1M | 543.7M | 463M | 538.2M | 156.9M | 47.4M | 539.3M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 60.6M | 51.4M | 45.2M | 45.1M | 37.5M | 37.1M | 34M | 34.1M | 34.1M | 34.1M |
| Non-Operating Income | -60.6M | -51.4M | -45.2M | -45.1M | -37.5M | -37.1M | -34M | -34.1M | -34.1M | -34.1M |
| Pretax Income | 439.4M | 66M | 292.9M | 282.5M | 522.1M | 444.8M | 521.3M | 144M | 41.1M | 537.8M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 108.6M | -1M | 76.8M | 43.5M | 93.1M | 82.8M | 101.3M | 27.2M | 7.6M | 112.5M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 331.5M | 155.1M | 186.2M | 391M | 425.1M | 358.7M | 422.8M | 116M | 35.3M | 426M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.18% | -0.53% | 0.2% | 1.1% | 0.09% | -0.16% | 0.18% | -0.73% | -0.7% | 11.07% |
| EPS (Diluted) | 7.40 | 3.59 | 4.33 | 9.09 | 10.46 | 9.42 | 11.49 | 3.21 | 0.98 | 11.70 |
| EPS Growth % | 0.18% | -0.51% | 0.21% | 1.1% | 0.15% | -0.1% | 0.22% | -0.72% | -0.69% | 10.94% |
| EPS (Basic) | 7.71 | 3.63 | 4.38 | 9.24 | 11.07 | 9.51 | 11.79 | 3.21 | 0.98 | 11.85 |
| Diluted Shares Outstanding | 44.8M | 43.2M | 43M | 43M | 40.6M | 38.1M | 36.4M | 36.1M | 36.1M | 36.4M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 13.78B | 14.22B | 15.47B | 12.4B | 12.49B | 13.44B | 14.25B | 14B | 14.61B | 15.27B |
| Asset Growth % | 0% | 0.03% | 0.09% | -0.2% | 0.01% | 0.08% | 0.06% | -0.02% | 0.04% | 0.05% |
| Total Investment Assets | 7.56B | 7.92B | 6.33B | 12.79B | 8B | 8.85B | 8.39B | 7.72B | 425.5M | 1.59B |
| Long-Term Investments | 7.56B | 7.92B | 6.33B | 6.63B | 7.26B | 8.05B | 8.39B | 7.72B | 425.5M | 0 |
| Short-Term Investments | 0 | 0 | 0 | 6.16B | 6.69B | 7.45B | 0 | 0 | 0 | 1.59B |
| Total Current Assets | 4.37B | 1.72B | 297.9M | 6.31B | 0 | 0 | 3.61B | 1.91B | 2.02B | 2.24B |
| Cash & Equivalents | 338.8M | 282.6M | 376.4M | 1.02B | 215.7M | 120.6M | 230.9M | 305M | 316.1M | 435.5M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | -1.65B | -3.7B | -9.98B | -10.79B | 0 | 0 | 0 | -1.59B |
| Goodwill & Intangibles | 186M | 184.8M | 192.6M | 178.8M | 178.8M | 178.8M | 178.8M | 178.8M | 178.8M | 178.8M |
| Goodwill | 186M | 184.8M | 192.6M | 178.8M | 178.8M | 178.8M | 178.8M | 178.8M | 178.8M | 178.8M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | -7.8B | 1.86B | 0 | -7.44B | -8.23B | 5.27B | -7.52B | 0 | 0 |
| Total Liabilities | 10.94B | 11.36B | 12.47B | 9.45B | 9.57B | 10.24B | 11.11B | 11.66B | 12.15B | 12.43B |
| Total Debt | 803.1M | 786.4M | 786.9M | 777.9M | 653.4M | 780.8M | 781.6M | 782.4M | 783.2M | 784.1M |
| Net Debt | 464.3M | 503.8M | 410.5M | -242.8M | 437.7M | 660.2M | 550.7M | 477.4M | 467.1M | 348.6M |
| Long-Term Debt | 803.1M | 786.4M | 786.9M | 777.9M | 653.4M | 780.8M | 781.6M | 782.4M | 783.2M | 722.3M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61.8M |
| Total Current Liabilities | 930.1M | 728M | 344.8M | 37.3M | 0 | 0 | 55.1M | 731.7M | 6.09B | 819.6M |
| Accounts Payable | 205.2M | 251.9M | 51.5M | 37.3M | 53.4M | 48.4M | 55.1M | 70.3M | 64.3M | 37.7M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -724.9M | -251.9M | 0 | 0 | -681.1M | -735.9M | -907.7M | -70.3M | 5.25B | -37.7M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 1000K | 1000K | 0 | 0 | 0 | 0 |
| Other Liabilities | 10.13B | 9.85B | 11.69B | 8.67B | -705.2M | -878.1M | 10.33B | 10.16B | 11.36B | 10.89B |
| Total Equity | 2.84B | 2.86B | 3B | 2.95B | 2.92B | 3.2B | 3.14B | 2.33B | 2.47B | 2.84B |
| Equity Growth % | 0% | 0% | 0.05% | -0.01% | -0.01% | 0.1% | -0.02% | -0.26% | 0.06% | 0.15% |
| Shareholders Equity | 2.84B | 2.86B | 3B | 2.95B | 2.92B | 3.2B | 3.14B | 2.33B | 2.47B | 2.84B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 1.8B | 1.88B | 1.98B | 2.18B | 2.41B | 2.67B | 2.98B | 2.99B | 2.91B | 3.21B |
| Common Stock | 600K | 600K | 600K | 600K | 600K | 600K | 600K | 600K | 600K | 600K |
| Accumulated OCI | 53.9M | 62.8M | 107.6M | -116.5M | 152.6M | 372.5M | 122.2M | -701.5M | -517.2M | -456.3M |
| Return on Equity (ROE) | 0.12% | 0.05% | 0.06% | 0.13% | 0.14% | 0.12% | 0.13% | 0.04% | 0.01% | 0.16% |
| Return on Assets (ROA) | 0.02% | 0.01% | 0.01% | 0.03% | 0.03% | 0.03% | 0.03% | 0.01% | 0% | 0.03% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.28x | 0.28x | 0.26x | 0.26x | 0.22x | 0.24x | 0.25x | 0.34x | 0.32x | 0.28x |
| Book Value per Share | 63.49 | 66.15 | 69.71 | 68.71 | 71.83 | 84.05 | 86.40 | 64.65 | 68.30 | 78.07 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 444.7M | 743.4M | 704.6M | 551.3M | 602.9M | 707.6M | 823.7M | 722.3M | 361.7M | 806.4M |
| Operating CF Growth % | -0.21% | 0.67% | -0.05% | -0.22% | 0.09% | 0.17% | 0.16% | -0.12% | -0.5% | 1.23% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 331.5M | 155.1M | 186.2M | 391M | 425.1M | 358.7M | 420M | 116M | 35.3M | 426M |
| Depreciation & Amortization | 30.2M | 30.7M | 30.1M | 24.6M | 21.6M | 18.2M | 16.9M | 12.9M | 6.3M | 1.5M |
| Stock-Based Compensation | 12.3M | 12M | 12.3M | 13.4M | 17.4M | 20.1M | 22.9M | 29M | 31.1M | 31M |
| Deferred Taxes | 53.1M | -13.2M | 39.8M | -23.4M | 12.5M | -23M | 25M | -46.5M | -24.6M | -18.8M |
| Other Non-Cash Items | -36.1M | 95.9M | -37.4M | -102.6M | -111.1M | -17.6M | -281.1M | 49.6M | 41.5M | 145.8M |
| Working Capital Changes | 53.7M | 462.9M | 473.6M | 248.3M | 237.4M | 351.2M | 620M | 561.3M | 272.1M | 220.9M |
| Cash from Investing | -171.5M | -495.4M | -506.3M | 271.3M | -311.9M | -608.8M | -460.2M | -507.6M | -228.5M | -541.5M |
| Capital Expenditures | -19.5M | -15.7M | -18.6M | -13.1M | -13.3M | -14.9M | -8M | -17.8M | -11.9M | -10.2M |
| Acquisitions | 44.3M | 0 | 0 | 635.7M | 34.7M | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -2.22B | -2.37B | -1.87B | -1.6B | -1.92B | -2.08B | -2.3B | -2.08B | -1.13B | -3.31B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | -1.1M | 12.1M | -9.5M | 0 | 0 | 0 | 0 | 0 | 0 | -600K |
| Cash from Financing | -301M | -300.8M | -111.7M | -171M | -1.1B | -193.9M | -253.2M | -140.6M | -122.1M | -145.5M |
| Dividends Paid | -74.2M | -80.4M | -86.8M | -94.3M | -386.2M | -99.5M | -102.2M | -108.9M | -117.2M | -124.1M |
| Share Repurchases | -127.3M | -105.6M | -37.2M | -57.7M | -563.6M | -212.8M | -162.6M | -30.8M | 0 | -26.7M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -1000K | -1000K | 0 | -1000K | -1000K | 1000K | 0 | 0 | 0 | 0 |
| Other Financing | 14.8M | -10.1M | 12.3M | -7.4M | 1.6M | -2.2M | 11.6M | -900K | -4.9M | 5.3M |
| Net Change in Cash | -34.5M | -56.2M | 150.6M | 722.8M | -805M | -95.1M | 110.3M | 74.1M | 11.1M | 119.4M |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K | 1000K | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 373.3M | 338.8M | 147.3M | 297.9M | 1.02B | 215.7M | 120.6M | 230.9M | 305M | 316.1M |
| Cash at End | 338.8M | 282.6M | 297.9M | 1.02B | 215.7M | 120.6M | 230.9M | 305M | 316.1M | 435.5M |
| Free Cash Flow | 418.9M | 721.9M | 686M | 538.2M | 589.6M | 692.7M | 815.7M | 704.5M | 349.8M | 796.2M |
| FCF Growth % | -0.24% | 0.72% | -0.05% | -0.22% | 0.1% | 0.17% | 0.18% | -0.14% | -0.5% | 1.28% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 9.35 | 16.71 | 15.95 | 12.52 | 14.52 | 18.18 | 22.41 | 19.52 | 9.69 | 21.87 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 91.3% | 98.34% | 93.14% | 93.67% | 89.32% | 90.77% | 89.9% | 97.35% | 99.31% | 91.35% |
| Medical Cost Ratio | 77.6% | 84.47% | 80.14% | 80.97% | 77.54% | 78.78% | 79.79% | 86.82% | 89.05% | 80.09% |
| Return on Equity (ROE) | 11.66% | 5.44% | 6.36% | 13.14% | 14.48% | 11.73% | 13.32% | 4.23% | 1.47% | 16.05% |
| Return on Assets (ROA) | 2.41% | 1.11% | 1.25% | 2.81% | 3.42% | 2.77% | 3.05% | 0.82% | 0.25% | 2.85% |
| Equity / Assets | 20.64% | 20.09% | 19.38% | 23.83% | 23.35% | 23.82% | 22.06% | 16.68% | 16.87% | 18.6% |
| Book Value / Share | 63.49 | 66.15 | 69.71 | 68.71 | 71.83 | 84.05 | 86.4 | 64.65 | 68.3 | 78.07 |
| Debt / Equity | 0.28x | 0.28x | 0.26x | 0.26x | 0.22x | 0.24x | 0.25x | 0.34x | 0.32x | 0.28x |
| Revenue Growth | -0.38% | -21.45% | 7.62% | 4.64% | 9.51% | -1.47% | 7.08% | 5.3% | 9.77% | 4.25% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Personal Lines | - | - | 1.58B | 1.71B | 1.82B | 1.84B | 1.93B | 2.11B | 2.44B | 2.56B |
| Personal Lines Growth | - | - | - | 7.92% | 6.70% | 1.31% | 4.63% | 9.51% | 15.59% | 5.00% |
| Core Commercial Lines | - | - | - | - | - | - | - | 1.95B | 2.22B | 2.32B |
| Core Commercial Lines Growth | - | - | - | - | - | - | - | - | 13.65% | 4.84% |
| Specialty Lines | - | - | - | - | - | - | - | 1.19B | 1.35B | 1.41B |
| Specialty Lines Growth | - | - | - | - | - | - | - | - | 13.68% | 4.49% |
| Other Operating | - | - | - | - | - | - | - | - | - | 12.4M |
| Other Operating Growth | - | - | - | - | - | - | - | - | - | - |
| Others | - | - | - | - | - | - | - | - | 15.4M | - |
| Others Growth | - | - | - | - | - | - | - | - | - | - |
| Commercial Lines | - | - | 2.4B | 2.55B | 2.65B | 2.68B | 2.84B | - | - | - |
| Commercial Lines Growth | - | - | - | 6.20% | 4.15% | 1.10% | 5.87% | - | - | - |
| All Others | - | - | - | - | 26M | - | - | - | - | - |
| All Others Growth | - | - | - | - | - | - | - | - | - | - |
| Other Property And Casualty | - | - | - | 14.2M | - | - | - | - | - | - |
| Other Property And Casualty Growth | - | - | - | - | - | - | - | - | - | - |
| Chaucer | 1.05B | 838.6M | 853M | - | - | - | - | - | - | - |
| Chaucer Growth | - | -20.22% | 1.72% | - | - | - | - | - | - | - |
| Property Liability And Casualty Insurance | 3.65B | 3.79B | - | - | - | - | - | - | - | - |
| Property Liability And Casualty Insurance Growth | - | 3.72% | - | - | - | - | - | - | - | - |
The Hanover Insurance Group, Inc. (THG) has a price-to-earnings (P/E) ratio of 14.5x. This may indicate the stock is undervalued or faces growth challenges.
The Hanover Insurance Group, Inc. (THG) grew revenue by 4.2% over the past year. Growth has been modest.
Yes, The Hanover Insurance Group, Inc. (THG) is profitable, generating $631.9M in net income for fiscal year 2024 (6.9% net margin).
Yes, The Hanover Insurance Group, Inc. (THG) pays a dividend with a yield of 2.00%. This makes it attractive for income-focused investors.
The Hanover Insurance Group, Inc. (THG) has a return on equity (ROE) of 16.1%. This is reasonable for most industries.
The Hanover Insurance Group, Inc. (THG) has a combined ratio of 91.3%. A ratio below 100% indicates underwriting profitability.